Afroza Ahammed, Senior Clinical Laboratory Scientist, Kaiser Permanente

Afroza Ahammed is a Senior Clinical Laboratory Scientist (CLS) at Kaiser Permanente. She has been providing quality patient care, which complies with local, state and federal requirements, for a decade now.

Born in Bangladesh, she resided and grew up in Qatar since three months of age; after finishing High School, she came to the US for higher studies. Afroza graduated from San Jose State University (SJSU) with a Bachelor's in Microbiology, later completed the SJSU Clinical Lab Scientist internship program in affiliation with Santa Clara Valley Medical Center (SCVMC). Upon passing the CLS (ASCP-BOC) exam, she joined Kaiser Permanente clinical laboratory as a generalist in 2008.

She had already completed most of the MA course works in Molecular and Microbial Biology at SJSU before joining the CLS program. The MA degree was conferred in 2010. Kaiser Permanente recognized her outstanding qualification and efforts in 2015 and she was promoted to a Senior CLS II classification.

Recently, Afroza has grown special interest in Transfusion medicine and Blood Bank management. So she worked for a year and half at Regional Medical Center (RMC) to learn and explore more about blood banking in a trauma center. Also, she started pursuing the specialist in Blood Banking (SBB) certification program at Rush University in 2020 and has passed the SBB (ASCP-BOC) exam lately. This certification has enabled her to gain profound scientific knowledge and expertise within the field; and with it, she hopes to navigate their BB Lab to future advancements and developments.

Growing up by the Persian Gulf, Afroza spent hours collecting sea shells and making sand castles, the beach always allures her. On her days off, she loves going to the beaches, traveling places, doing nature photography, cooking, and watching movies with her family.

Comments

Sachi Ahmed, Senior Scientist, Merck & Co.

Sachi Ahmed is a senior scientist at Merck & Co. working on ADCs and bispecifics. With a background in chemical engineering, she has been a researcher in the field of cancer for 20 years and is a published author in scientific journals, including a publication in Nature magazine on nasal delivery of an IgM drug for SARS-CoV-2 variants . Sachi is also a key inventor on a US patent for glyco-engineered IgMs . Prior to Merck, she was at IGM biosciences for 7 years where she led the research antibody production team focused on novel approaches in cancer and Covid-19 therapeutics. She has also previously worked for biotechnology companies such as Abbott, Abbvie, and Merck and has expertise in in-vitro glycoengineering and antibody production to support the development of innovative biologics. Sachi was a founder of the PTPS (Peers Teaching Peers Science) program at the FAME Charter School in Fremont, CA, aimed to inspire children to gain confidence and interest in science and engin...

Tahmida Mahmud, Ph.D., Director of Engineering, AI, Nauto

Tahmida Mahmud is the Director of Engineering, AI at Nauto, Inc leading both the Perception & Data Science teams. The teams develop AI-based algorithms related to critical external safety features (ADAS) and driver monitoring system (DMS) for automotive fleets focusing on development, large-scale deployment, and monitoring of machine learning/deep learning solutions to mitigate distracted driving, prevent collisions, model risk, coach drivers, and contribute to the advancement of self-driving technology. She received her Masters and Ph.D. in Electrical Engineering from University of California, Riverside. Her research focus is computer vision and machine learning and she has several publications in her field. She finished her Bachelors in Electrical and Electronic Engineering from Bangladesh University of Engineering and Technology (BUET). She was listed as one of the 30 influential women advancing AI in 2020 by ReWork. Apart from her passion to use technology to have a real i...

Kazi Tasneem, Ph.D., Preclinical Senior Scientist, Genentech Inc.

Kazi Tasneem is a Preclinical Senior Scientist at Genentech Inc., specializing in antibody drug development with over 3 years of industry experience. She focuses on computational prediction models for drug transport in preclinical settings, overseeing the design/strategy and interpretation of pharmacokinetics/pharmacodynamics studies for antibody/biologics in cancer immunotherapy. She holds a PhD in Chemical Engineering from Vanderbilt University, a Master’s degree in Materials Science and Engineering from the University of Central Florida and a Master’s degree in Environmental Engineering from Carnegie Mellon University. She completed her Bachelor’s degree in Chemical Engineering from Bangladesh University of Engineering and Technology (BUET). Kazi is an Advisory Council Member of the Engineering Leadership Program at California State University, Chico. She has received prestigious awards, including the Best Abstract Awa...

Silicon Valley Bangladeshi Women in STEM

Search This Blog